دورية أكاديمية
Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus : Results over 52 weeks
العنوان: | Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus : Results over 52 weeks |
---|---|
المؤلفون: | Leiter, Lawrence A, Gross, Jorge Luiz, Chow, Francis C C, Miller, Diane, Johnson, Susan L, Ahrén, Bo |
المصدر: | Journal of Diabetes and its Complications; 31(8), pp 1283-1285 (2017) ; ISSN: 1056-8727 |
بيانات النشر: | Elsevier |
سنة النشر: | 2017 |
المجموعة: | Lund University Publications (LUP) |
مصطلحات موضوعية: | Endocrinology and Diabetes, Basal insulin, Clinical trial, Combination therapy, Glucagon-like peptide-1 receptor agonist, Type 2 diabetes |
الوصف: | We have previously reported that once-weekly albiglutide was noninferior to thrice-daily lispro for glycemic lowering, with decreased weight and risk of hypoglycemia, in patients inadequately controlled on basal insulin over 26 weeks. Findings after 52 weeks reveal similar responses to albiglutide as an add-on to insulin glargine. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
العلاقة: | https://lup.lub.lu.se/record/068b6333-3237-40d6-a68c-8ddf0f9d5956Test; http://dx.doi.org/10.1016/j.jdiacomp.2017.05.010Test; scopus:85020115367; pmid:28587789; wos:000406081200008 |
DOI: | 10.1016/j.jdiacomp.2017.05.010 |
الإتاحة: | https://doi.org/10.1016/j.jdiacomp.2017.05.010Test https://lup.lub.lu.se/record/068b6333-3237-40d6-a68c-8ddf0f9d5956Test |
رقم الانضمام: | edsbas.227BA33F |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.jdiacomp.2017.05.010 |
---|